Biggest News Aggregation in the World
📰 Licensing News

Page 74 - Licensing News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Licensing. Real-time updates on events, politics, business and more.

Mirati Therapeutics Receives Approval from the MHRA for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation

/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a commercial stage biotechnology company, today announced the United Kingdoms Medicines and...
United Kingdom Great Britain Alan Sandler University Hospital Birmingham Healthcare Products Regulatory Agency Prnewswire Mirati Therapeutics Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science